Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome

• Conditions: Acute Coronary Syndrome; Coronary Stenting; Antiplatelet Therapy

• Registration Number: NCT02099422
• Lead Sponsor: Hôpital de la Timone

Brief Summary

Comparison of two antiplatelet strategies between months 1 and 12 after coronary stenting for ACS. Efficiency and tolerance évaluation

Detailed Description

Not available

Study Timeline

• Study Start: 2013-01
• Status Verified: 2014-03
• Study First Submitted: 2014-03-26
• Study First Submitted QC: 2014-03-26
• Last Update Submitted: 2014-03-26
• Study First Posted: 2014-03-28
• Last Update Posted: 2014-03-28
• Primary Completion: 2015-01
• Study Completion: 2016-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• ACS and coronary stenting one month ago

Exclusion Criteria

• age under 18 and pregnancy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
combined ischemic and hemorragic endpoint	12 months

Trial Locations

Locations (1)

CHU Timone hospital . Sc CARDIOLOGIE. Rue saint Pierre.; 🇫🇷 Marseille, France